Dipna Pharmachem Limited (BOM:543594)
8.71
+0.19 (2.23%)
At close: Mar 6, 2026
Dipna Pharmachem Revenue
Dipna Pharmachem had revenue of 723.28M INR in the half year ending September 30, 2025, a decrease of -2.30%. This brings the company's revenue in the last twelve months to 1.07B, down -41.07% year-over-year. In the fiscal year ending March 31, 2025, Dipna Pharmachem had annual revenue of 1.25B, down -23.99%.
Revenue (ttm)
1.07B
Revenue Growth
-41.07%
P/S Ratio
0.21
Revenue / Employee
n/a
Employees
13
Market Cap
223.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.25B | -394.20M | -23.99% |
| Mar 31, 2024 | 1.64B | 644.10M | 64.46% |
| Mar 31, 2023 | 999.27M | 271.72M | 37.35% |
| Mar 31, 2022 | 727.55M | 417.56M | 134.70% |
| Mar 31, 2021 | 310.00M | 4.61M | 1.51% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Checkpoint Trends | 2.95B |
| Medico Intercontinental | 845.68M |
| Constronics Infra | 598.94M |
| Medistep Healthcare | 496.55M |
| Chandra Bhagat Pharma | 493.95M |
| Zenlabs Ethica | 493.24M |
| Evoq Remedies | 407.29M |
| Muller & Phipps (India) | 70.90M |